Global update: Brazil

Regenerative Medicine

Volumn 7, Issue 6 SUPPL., 2012, Pages 144-147

  Mendez Otero, Rosalia ^a   Campos De Carvalho, Antonio Carlos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; EMBRYONIC STEM CELL; FUNDING; HEALTH PROGRAM; HUMAN; INVESTMENT; LAW; MEDICAL SOCIETY; MESENCHYMAL STEM CELL; NONHUMAN; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; REGENERATIVE MEDICINE; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

ANIMALS; BRAZIL; HUMANS; PRIVATE SECTOR; REGENERATIVE MEDICINE; STEM CELL RESEARCH;

EID: 84870694801     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.84     Document Type: Article

References (15)

1. McMahon DS, Singer PA, Daar AS, Thorsteinsdóttir H. Regenerative medicine in Brazil: small but innovative. Regen. Med. 5(6), 863-876 (2010).
2. Fraga AM, Sukoyan M, Rajan P et al. Establishment of a Brazilian line of human embryonic stem cells in defined medium: implications for cell therapy in an ethnically diverse population. Cell Transplant. 20(3), 431-440 (2011).
3. Burt RK, Loh Y, Cohen B et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a Phase I/II study. Lancet Neurol. 8(3), 244-253 (2009).
4. Voltarelli JC, Couri CE, Stracieri AB et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed Type 1 diabetes mellitus. JAMA 297(14), 1568-1576 (2007).
5. Couri CE, Oliveira MC, Stracieri AB et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed Type 1 diabetes mellitus. JAMA 301(15), 1573-1579 (2009).
6. Dohmann HF, Silva SA, Sousa AL et al. Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction - MiHeart/AMI study. Trials 9, 41 (2008).
7. Perin EC, Dohmann HF, Borojevic R et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107(18), 2294-2302 (2003).
8. Ribeiro Dos Santos R, Rassi S, Feitosa G et al. Chagas Arm of the MiHeart Study Investigators. Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial. Circulation 125(20), 2454-2461 (2012).
9. Barbosa da Fonseca LM, Battistella V, de Freitas GR et al. Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 120(6), 539-541 (2009).
10. Battistella V, de Freitas GR, da Fonseca LM et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen. Med. 6(1), 45-52 (2011).
11. Barbosa da Fonseca LM, Gutfilen B, Rosado de Castro PH et al. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intraarterial injection. Exp. Neurol. 221(1), 122-128 (2010).
12. Friedrich MA, Martins MP, Araújo MD et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant. 21(Suppl. 1), S13-S21(2012).
13. Couto BG, Goldenberg RC, da Fonseca LM et al. Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int. 31(3), 391-400 (2011).
14. Tura BR, Martino HF, Gowdak LH, dos Santos RR et al. Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study. Trials 8, 2 (2007).
15. Brazilian Network for Cell Therapy (Rede Nacional de Terapia Celular [RNTC]) www.rntc.org.br